EP0188485A1 - Sonde et procede pour le diagnostic du sexe d'un embryon humain - Google Patents
Sonde et procede pour le diagnostic du sexe d'un embryon humainInfo
- Publication number
- EP0188485A1 EP0188485A1 EP85903297A EP85903297A EP0188485A1 EP 0188485 A1 EP0188485 A1 EP 0188485A1 EP 85903297 A EP85903297 A EP 85903297A EP 85903297 A EP85903297 A EP 85903297A EP 0188485 A1 EP0188485 A1 EP 0188485A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- probe
- dna
- hybridization
- cells
- sex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000523 sample Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 25
- 210000001161 mammalian embryo Anatomy 0.000 title abstract description 11
- 239000012634 fragment Substances 0.000 claims abstract description 23
- 238000009396 hybridization Methods 0.000 claims abstract description 21
- 210000004027 cell Anatomy 0.000 claims abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 12
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 11
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 11
- 210000002593 Y chromosome Anatomy 0.000 claims abstract description 10
- 238000000338 in vitro Methods 0.000 claims abstract description 10
- 238000001514 detection method Methods 0.000 claims abstract description 5
- 244000005700 microbiome Species 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 33
- 210000002257 embryonic structure Anatomy 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000003745 diagnosis Methods 0.000 claims description 7
- 238000002405 diagnostic procedure Methods 0.000 claims description 7
- 210000001182 human Y chromosome Anatomy 0.000 claims description 7
- 108010077544 Chromatin Proteins 0.000 claims description 5
- 210000003483 chromatin Anatomy 0.000 claims description 5
- 210000003754 fetus Anatomy 0.000 claims description 5
- 239000003298 DNA probe Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 108020004635 Complementary DNA Proteins 0.000 claims description 2
- 238000010804 cDNA synthesis Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 230000002759 chromosomal effect Effects 0.000 claims description 2
- 239000002299 complementary DNA Substances 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 230000000717 retained effect Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 210000000349 chromosome Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 108010034791 Heterochromatin Proteins 0.000 description 7
- 239000000020 Nitrocellulose Substances 0.000 description 7
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 7
- 210000004458 heterochromatin Anatomy 0.000 description 7
- 229920001220 nitrocellulos Polymers 0.000 description 7
- 229940079938 nitrocellulose Drugs 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 210000004252 chorionic villi Anatomy 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 210000002993 trophoblast Anatomy 0.000 description 6
- 238000001574 biopsy Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000001766 X chromosome Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000006935 Simonis synthesis reaction Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000002669 amniocentesis Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004090 human X chromosome Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 108091035233 repetitive DNA sequence Proteins 0.000 description 1
- 102000053632 repetitive DNA sequence Human genes 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- ILXAOQAXSHVHTM-UHFFFAOYSA-M sodium;2-amino-2-(hydroxymethyl)propane-1,3-diol;chloride Chemical compound [Na+].[Cl-].OCC(N)(CO)CO ILXAOQAXSHVHTM-UHFFFAOYSA-M 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Definitions
- the invention relates to a probe comprising a nucleic acid sequence specific for the human Y chromosome and to a method for diagnosing the sex of a human embryo.
- the object of the invention is to provide an even more specific probe for the Y chromosome and an in vitro diagnostic method capable of being implemented on a total genomic DNA, without prior separation of any of its constituents.
- the invention therefore aims to combine the earliness of the diagnosis, the speed and reliability of its implementation.
- the invention stems from a research project, certain results of which were the subject of first publications. This is more particularly the article by CE.BISHOP et al. titled “Sinqle-Copy DNA Specified Sequences for the Human Y Chromosome", (Nature Vol. 303, N ° 5 920, on. 831 - 832, June 30, 1983 ) and the article by C. BISHOP et al. entitled “Extensive Sequence Homologies Between Y And-Other Human- Chromosomes” (J. Mol. Biol. [1984] 173, 403-417).
- the second article describes more particularly the conditions under which the amplified cosmids containing exclusively inserts of human origin were obtained, how the latter were further sorted, by digestion with the restriction enzyme EcoRI and subcloning of the fragments obtained in pBR 322, to finally obtain 45 probes containing inserts originating from the human Y chromosome and probably unrelated to each other.
- These probes were further characterized by hybridization experiments under strict conditions with series of fragments obtained from genomic DNA treated by complete digestion with the restriction enzyme EcoRI, then separated by electrophoresis in gels. of agarose, before being transferred to a nitro-cellulose filter or a similar paper, known under the initials DBM (ALWINE, JC [1977] Proc.Nat.Acad. SCi.
- the invention follows from the discovery that one of these EcoRI fragments, called “Probe 49 F” was capable not only of giving rise to selective hybridization with a particular DNA fragment obtained from series of EcoRI fragments transferred as indicated above and obtained from Y chromosomes, but also to give rise to an equally selective hybridization when this is carried out on a single spot of DNA originating from human male embryo, if necessary previously fragmented, this spot having been obtained for example by filtration of a solution of total genomic DNA through a nitrocellulose filter pad, according to the so-called "Dot-Blot” technique.
- the above-mentioned prior fragmentation can be carried out by simple ultrasonic treatment (sonication) of the DNA preparation to be tested.
- the invention relates more generally to any DNA containing a hybridizable fragment under the strict conditions recalled below, with the EcoRI fragment of 2.8 kb obtained from the euchromatic region located between the centromere and the heterochromatin (when the latter is present) of the large arm of a Y chromosome, this fragment having been deposited on 06/29/1984 at the National Collection of Cultures of Microorganisms of the INSTITUT PASTEUR of Paris (CNCM) under N ° 1- 312.
- CNCM National Collection of Cultures of Microorganisms of the INSTITUT PASTEUR of Paris
- any fragment of chromosome Y which forms stable hybrids with the above-mentioned EcoRI fragment deposited at the CNCM in the presence of a solution of 0.1 SSC at 65-68oC, more particularly at 68 ° C.
- This condition of stability of the hybrid can be verified in particular during the washing of the hybrid previously formed on a suitable support / such as a nitrocellulose filter or the like, with a solution of 0.1 ⁇ SSC (SSC being a 0.5 M NaCl solution; 0.15 M sodium citrate at pH 7.0 at 65 - 68 ° C, more particularly 68 ° C).
- SSC being a 0.5 M NaCl solution; 0.15 M sodium citrate at pH 7.0 at 65 - 68 ° C, more particularly 68 ° C.
- the invention relates to any plasmid or other vector containing an insert corresponding to the above definition.
- hybridization stability conditions which have been defined above are strict with regard to the selectivity of the hybridization.
- the ion content of the 0.1 SSC solution being low, the hybridization remains stable only to the extent that the two chains involved in the constitution of the hybrid have a very high degree of complementarity. The selectivity of this probe even with respect to,.
- the DNA preparation required for the implementation of the diagnosis according to the invention can consist of any cells of the embryo capable of being obtained at a very early stage of gestation, in particular between the 6th and 8th week, for example from tr ⁇ phoblasts (ie from chorionic cells) or from chorionic villi. Examples of implementation of the method according to the invention will be described below.
- the invention therefore also relates to a nrocedé oour the in vitro diagnosis of sex, orocé35 characterized nar the contacting of a DNA containing all or part of the hybridizable fraqment above-defined with the practically total DNA coming from cells taken from the fetus whose sex must be determined, this total DNA having been previously extracted from said cells or simply made accessible to the probe, or for example by lysis of. cells, and by bringing the hybrid formed into contact, whether already during or after the hybridization (especially during washes) with a solution with low ionic strength and at a temperature favoring together highly selective hybridizations of the probe with a sequence of complementary DNA present in the chromatin of the human Y chromosome.
- the aforesaid brought into contact is aerated with a 0.1 SSC solution at a temperature of 65 - 68 ° C, more particularly 68 ° C.
- the probes are radioactively marked.
- the invention is not limited to this method of marking.
- the probes can be modified by a single group allowing their coupling, direct or indirect, for example with an enzyme whose presence can be revealed by its action with respect to a specific substrate, preferably a chromogenic substrate, or with a fluorescent or luminescent molecule. Coupling modes of this type have been envisaged, for example, in French patents 78 10975 and 81 27631 or in published European patent application 0063 879.
- a preferred embodiment of the method according to the invention for the detection of sex on cells originating from a fetus or. human embryo will include:
- nucleic acids thus fixed or made accessible into contact with the labeled probe according to the invention under conditions allowing effective hybridization to be carried out, when the DNAs studied comprise a Y chromosome;
- kits or "kits” containing a probe in accordance with the invention and, where appropriate, control chromosomal preparations (originating from male and / or female embryos) and any other reagents necessary for the production of a in vitro diagnostic test.
- the DNA analysis was carried out on cells belonging to the chorionic villi or to blood cells taken from the embryos studied. The technique known as "Dot blot" was used. The tests can be carried out on quantities of DNA less than 3 ⁇ ig. The trials only last two days. Cell samples
- the blood samples were provided by hospitals. Trophoblast samples were obtained from placental biopsies performed after the first 6 to 8 weeks of gestation. In a number of cases, biopsies have been taken in women before abortion and after having obtained their informed consent. A 1.7 mm diameter DYONIC biopsy forceps was introduced cross-cervically into the uterine cavity using a real-time ultrasound guide according to the methods described by SIMONI G. et al. (Hum. Genêt. [1983]; 63 349-57) and WARD R.H.T. et al. (Brit.Med. H. 1983: 1542-4).
- trophoblast villi i.e., chorion
- the tissues were washed in an isotonic and sterile saline solution and then examined immediately under a dissecting microscope. All maternal decidual cells have been carefully separated from the villi using appropriate tweezers. From 10 to 50 mg of trophoblast villi were then used for the analysis of their nucleic acids. The products of conception were used for karyotype or chromatin studies Trophoblast villi have also been used. In seven cases, small parts of these villi were obtained by dissection from placental cotyledons obtained after cesarean sections.
- Fibroblasts obtained from embryos were cultured in vitro according to standard procedures (RPMI 1640 fetal calf serum, antibiotics, in an atmosphere containing 5% CO 2 ).
- the karyotypes were established after in vitro cultures for 12-20 days (second or third pass) using standard techniques. Giemsa stains and molecular weight separation techniques (C Banding techniques: CBG) were used. Two to ten mitoses were analyzed.
- the chromatins of the chromosomes involved in the constitution of sex were studied on cells at the interphase level supplied from cultures of fibroblasts stained with toluidine blue. From 100 to 200 nuclei were counted.
- Preparation of the nucleic acids and analysis A) Preparation of the DNA obtained from blood cells: 10 ml of blood were collected in a ml of 5% EDTA. The serum was removed by centrifugation. The red blood cells were lysed in 0.17 M NH 4 Cl and the leukocytes were collected by centrifugation. They were lysed in a solution containing 7 M urea, 2% sodium dodecyl sulfate (SDS), 0.2 M NaCl, 10 mM Tris at pH 8 and 1 mM EDTA. The solution was extracted twice with an equal volume mixture of phenol and chloroform, then twice with chloroform before being precipitated with ethanol.
- SDS sodium dodecyl sulfate
- the precipitate was taken up, dissolved in a 10 mM Tris solution, 1 mM EDTA and containing ribonuclease A (50 ⁇ g / ml). The solution was incubated at 37 ° C for one hour, then supplemented with the following products to finally obtain a concentration in 1% SDS, 10 mM EDTA and proteinase K 100 ⁇ g / ml. The solution was then incubated for two hours. The solution was then extracted once with chloroform, dyalized in a 10 mM Tris solution pH 8, 1 mM EDTA overnight, before being precipitated again with ethanol.
- the DNAs were treated with ultrasound, denatured in a 0.4M NaOH solution and 1 M NaCl at 4 ° C for half an hour.
- the solution was neutralized just before filtration through a nitrocellulose filter in a 1.5 M Tris-NaCl solution, pH 7. Before filtration the nitrocellulose filter had been washed in a 6 x SSC solution. After filtration the filter was dried at 80 ° C for two hours, then hybridized in 6 x SSC, 1 x DENHARDT, for
- the probe according to the invention (which essentially contains a single sequence, as opposed to earlier probes essentially consisting of repetitive sequences) perfectly discriminates the male and female chromosomes, even when these have the following anomalies: in the case of male chromosomes, loss of part or all of the heterochromatin and in the case of female chromosomes, translocation into the X chromosome of certain fragments of heterochromatin normally considered to belong to the heterochromatin of group Y of the male chromosomes .
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8410408 | 1984-06-29 | ||
FR8410408A FR2566911A1 (fr) | 1984-06-29 | 1984-06-29 | Sonde et procede pour le diagnostic du sexe d'un embryon humain |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0188485A1 true EP0188485A1 (fr) | 1986-07-30 |
Family
ID=9305658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP85903297A Withdrawn EP0188485A1 (fr) | 1984-06-29 | 1985-06-28 | Sonde et procede pour le diagnostic du sexe d'un embryon humain |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0188485A1 (en)) |
ES (1) | ES8608683A1 (en)) |
FR (1) | FR2566911A1 (en)) |
GR (1) | GR851598B (en)) |
PT (1) | PT80743B (en)) |
WO (1) | WO1986000342A1 (en)) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769319A (en) * | 1985-05-31 | 1988-09-06 | Salk Institute Biotechnology Industrial Associates, Inc. | Nucleic acid probes for prenatal sexing |
EP0261172A1 (en) * | 1986-02-21 | 1988-03-30 | Whitehead Institute For Biomedical Research | Y-specific dna hybridization probes and uses therefor |
FR2595100B1 (fr) * | 1986-02-28 | 1990-02-09 | Agronomique Inst Nat Rech | Sondes moleculaires d'adn specifique du genome male de mammiferes, notamment du genre bos, presentant des sequences d'adn specifique du sexe male, procede de preparation de telles sondes et procede de determination du sexe d'embryons et de foetus des mammiferes susdits, a l'aide de ces sondes |
FR2603701B2 (fr) * | 1986-02-28 | 1990-09-21 | Agronomique Inst Nat Rech | Applications des sondes moleculaires d'adn specifique du genome male de mammiferes, notamment du genre bos, au controle de la presence du chromosome y dans une population de spermatozoides et a la separation des spermatozoides en deux populations de spermatozoides porteurs respectivement du chromosome y et du chromosome x pour leur utilisation pour l'insemination artificielle |
CA1296270C (en) * | 1986-08-12 | 1992-02-25 | The Australian National University | Sex determination in ruminants using y-chromosome specific polynucleotides |
FR2619819B1 (fr) * | 1987-08-27 | 1990-08-10 | Agronomique Inst Nat Rech | Sondes moleculaires d'adn specifique du genome male de ruminants, notamment de la sous-famille des bovines et en particulier du genre bos, sequences flanquantes pour l'amplification de ces sondes et applications desdites sondes |
US5328827A (en) * | 1987-08-27 | 1994-07-12 | Institut National De La Recherche Agronomique - Inra | Specific DNA molecular probes for Bos-type male genome |
WO1989002440A2 (en) * | 1987-09-21 | 1989-03-23 | Whitehead Institute For Biomedical Research | Y-specific dna hybridization probes and uses therefor |
WO1989007154A1 (en) * | 1988-01-29 | 1989-08-10 | Advanced Riverina Holdings Limited | Determination of genetic sex in ruminants using y-chromosome-specific polynucleotides |
JP2693776B2 (ja) * | 1988-02-24 | 1997-12-24 | 科学技術振興事業団 | Dnaプローブ及びそれを用いたヒト胎児の性別判定法 |
FR2635116B1 (fr) * | 1988-08-08 | 1990-11-02 | Georges Michel | Procede pour la determination du sexe d'embryons de ruminants, kit ou necessaire pour la mise en oeuvre du procede |
US5840482A (en) * | 1990-10-10 | 1998-11-24 | The Regents Of The University Of California | Y chromosome specific nucleic acid probe and method for determining the Y chromosome in situ |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE735915C (de) * | 1939-07-27 | 1943-06-01 | Waffen Und Munitionsfabriken A | Vorrichtung zum gleichzeitigen Messen der Wandstaerke und deren Verlauf laengs des Umfanges von zylindrischen Hohlkoerpern an mindestens drei verschiedenen Stellen |
NO149296C (no) * | 1978-03-17 | 1984-03-21 | Johde Fa | Maaleapparat for sylinderformete gjenstander |
DD154846B1 (de) * | 1980-11-27 | 1987-03-11 | Ursula Barth | Verfahren und auswerteeinrichtung zur angenaeherten paarungsdurchmesserbestimmung rotationssymmetrischer teile |
-
1984
- 1984-06-29 FR FR8410408A patent/FR2566911A1/fr not_active Withdrawn
-
1985
- 1985-06-28 PT PT80743A patent/PT80743B/pt unknown
- 1985-06-28 ES ES544664A patent/ES8608683A1/es not_active Expired
- 1985-06-28 EP EP85903297A patent/EP0188485A1/fr not_active Withdrawn
- 1985-06-28 GR GR851598A patent/GR851598B/el unknown
- 1985-06-28 WO PCT/FR1985/000178 patent/WO1986000342A1/fr not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO8600342A1 * |
Also Published As
Publication number | Publication date |
---|---|
ES8608683A1 (es) | 1986-07-16 |
GR851598B (en)) | 1985-11-25 |
WO1986000342A1 (fr) | 1986-01-16 |
PT80743A (fr) | 1985-07-01 |
ES544664A0 (es) | 1986-07-16 |
FR2566911A1 (fr) | 1986-01-03 |
PT80743B (fr) | 1986-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4404553B2 (ja) | 単離された母体血液の胎児細胞に対する出生前診断の方法 | |
Liu et al. | Rapid mini-preparation of fungal DNA for PCR | |
Hamada et al. | Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age | |
DE69029563T2 (de) | Verfahren zur Nukleinsäureextraktion und PCR-Amplifizierung ohne Gebrauch von proteolytischem Enzym | |
JP2593021B2 (ja) | ウシ胚の性の識別方法 | |
WO1986000342A1 (fr) | Sonde et procede pour le diagnostic du sexe d'un embryon humain | |
EP0477296A1 (en) | Prenatal bovine sex determination using male-specific oligonucleotides | |
Majiwa et al. | A repetitive deoxyribonucleic acid sequence distinguishes Trypanosoma simiae from T. congolense | |
US6605439B2 (en) | Extraction, amplification and sequential hybridization of fungal cell DNA and process for detection of fungal cells in clinical material | |
JP3803935B2 (ja) | 真菌細胞dnaの抽出、増幅および逐次ハイブリッド形成、並びに臨床物質中における真菌細胞の検出法 | |
CA1312565C (en) | Molecular probes for dna specific for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus bos, the process for their preparationand the use of these probes for determining the sex of ruminant embryos and fetuses and for checking the presence of the y chromosome | |
EP0670373A1 (en) | Probe for diagnosing infectious diseases | |
Van Dekken et al. | Enzymatic production of single-stranded DNA as a target for fluorescence in situ hybridization | |
Fukushima et al. | Identification of male bloodstains by dot hybridization of human Y chromosome-specific deoxyribonucleic acid (DNA) probe | |
WO1992014840A1 (fr) | Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile | |
Stetten et al. | Prenatal identification of small mosaic markers of different chromosomal origins | |
EP0580621B1 (fr) | Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile | |
Tsuchiya et al. | The “Spanning Protocol”: A new DNA extraction method for efficient single-cell genetic diagnosis | |
CA2072231C (en) | Determination of genetic sex in fish | |
AU621556B2 (en) | Specific dna molecular probes for bos-type male genome | |
Di Bona et al. | A (15; 17) translocation not associated with acute promyelocytic leukaemia | |
Detrich III et al. | Comparative genomics in erythropoietic gene discovery: synergisms between the Antarctic icefishes and the zebrafish | |
KR100444432B1 (ko) | 프리마틴 진단용 프로브 | |
Musatova et al. | Comparison of Amplification Methods of Single Trophoblast Cells for Their Subsequent Analysis Using Metaphase Comparative Genomic Hybridization | |
Jiang et al. | Constructing cDNA libraries with fewer clones that contain long poly (dA) tails |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19860227 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE GB IT LI LU NL SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GUELLAEN, GEORGES Inventor name: WEISSENBACH, JEAN Inventor name: TIOLLAIS, PIERRE Inventor name: KAPLAN, LILIANA Inventor name: VERGNAUD, GILLES |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19871016 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TIOLLAIS, PIERRE Inventor name: WEISSENBACH, JEAN Inventor name: KAPLAN, LILIANA Inventor name: GUELLAEN, GEORGES Inventor name: VERGNAUD, GILLES |